Browse by Topic

About 400 men with and without HIV, median age 60 years, participating in a sub-study of the MACS (Multicenter AIDS Cohort Study), were evaluated for body composition (waist circumference, abdominal visceral and subcutaneous adipose tissue, sarcopenia, and osteopenia/osteoporosis) and presence of frailty (Fried definition). The frailty frequency was 16% for men with HIV and 8% for men without HIV (2.43 increased odds of frailty).

About 400 men with and without HIV, median age 60 years, participating in a sub-study of the MACS (Multicenter AIDS Cohort Study), were evaluated for body composition (waist circumference, abdominal visceral and subcutaneous adipose tissue, sarcopenia, and osteopenia/osteoporosis) and presence of frailty (Fried definition). The frailty frequency was 16% for men with HIV and 8% for men without HIV (2.43 increased odds of frailty).

Utilizing an electronic medical record review in 250 adults (median age of 50 years) with HIV infection, substance dependence, or ever injection drug use, various categories of medication intake were determined. These categories included: overall systemically active; overall active but excluding antiretroviral (ARV); sedating, non-opioid sedating including gabapentin, trazodone, other anti-depressive medications; and opioids. The outcomes were self reported and included falls or accidents requiring medical attention and any fractures in the previous year.

Many people living with HIV use complementary and alternative medicine (CAM) to manage symptoms, chronic medical conditions, or to optimize health. This study looked at different types of CAM among people living with HIV who were also taking ART. The study also compared characteristics of people who used CAM compared to those who did not. The data are from veterans who participated in the Veterans Aging Cohort Study between 2012-2015.

Depression is known to be frequent in adults with HIV and to complicate management. However, what is not so clear is how the length of depression status over time can affect outcomes. In a study of almost 6000 patients, median age 44, with 2 or more depression assessments in the period 2005 to 2015, it was possible to address this question.

The National Cancer Institute projects that the proportion of adult persons with HIV in the US aged 65 years and older will increase from 8.5% to 21.4% in 2030. There will be a decrease in age-specific cancer rates for Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer, lung cancer, Hodgkin lymphoma and other cancer types combined through 2030. However, absolute numbers of lung cancer will increase. Also, prostate cancer rates and numbers are projected to increase during this time period.

The National Cancer Institute projects that the proportion of adult persons with HIV in the US aged 65 years and older will increase from 8.5% to 21.4% in 2030. There will be a decrease in age-specific cancer rates for Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer, lung cancer, Hodgkin lymphoma and other cancer types combined through 2030. However, absolute numbers of lung cancer will increase. Also, prostate cancer rates and numbers are projected to increase during this time period.